Constipation may be considered chronic if you've experienced two or more of these symptoms for the last three months.
This clinical research study is evaluating an investigational drug (lubiprostone) for children ages 6 to 17 with constipation. The investigational drug is a pill that is taken twice a day. It is designed to increase fluid secretion in the intestines which may help bowel movements to pass more smoothly. It may also help relieve symptoms associated with constipation such as straining and abdominal bloating.
What will happen during this research study?
If your child passes the initial screening process, your child will be enrolled in the study.
Your child will take one capsule, twice a day for 12 weeks provided by the study. There will be a
total of 6 office visits and 2 telephone calls during the study.
An electronic diary will be provided in order to collect data for the research study. The questions in the diary will need to be answered every day. In addition, you and your child will answer questions about your child’s health at each clinic visit.